GLAXOSMITHKLINE PLC

GSK

Delayed - 07/27 11:38:11 am
1399.2GBX	-0.04%

Turn to zoom

Prev.	1397.0000
Open	1392.8000
High	1401.8000
Low	1383.2650
Volume	3 926 470

14h ago	GlaxoSmithKline Pharmaceuticals' : Consolidated Net Profit Climbs in Fiscal Q1
14h ago	GlaxoSmithKline : Shingles Vaccine Gets Expanded US Nod For...
22h ago	BioNTech : Plans Development of First mRNA-Based Malaria Vaccine
1d ago	GlaxoSmithKline ( '') (Form 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)

	Short Term	Mid-Term	Long Term
Trend	Neutral	Bullish	Neutral
Resistance	1 444	1 444	1 526
Spread/Res.	-3,1%	-3,1%	-8,3%
Spread/Supp.	0,32%	5,2%	18%
Support	1 395	1 330	1 191

Sales 2021	33 019 M 45 858 M 45 858 M
Net income 2021	3 385 M 4 701 M 4 701 M
Net Debt 2021	21 463 M 29 809 M 29 809 M
P/E ratio 2021	20,4x
Yield 2021	5,71%

Capitalization	70 047 M 96 813 M 97 285 M
EV / Sales 2021	2,77x
EV / Sales 2022	2,59x
Nbr of Employees	94 066
Free-Float	92,2%

GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology...

>> Read more

Sector :

Other Pharmaceuticals

Calendar :

2021-07-28 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	27
Last Close Price	1 399,80 GBX
Average target price	1 518,63 GBX
Spread / Average Target	8,49%